Multiple sclerosis lesions are characterized by inflammation, demyelination and a variable degree of axonal loss. The patterns of inflammation in MS lesions are compatible with a T-lymphocyte mediated immune reaction. The formation of demyelinated plaques, however, seem to require additional immunological mechanisms. In this review evidence is discussed for a pathogenetic role of demyelinating antibodies, toxic macrophage products, cytotoxic T-cells as well as metabolic disturbances of oligodendrocytes. It is suggested that the pathological heterogeneity regarding the patterns and extent of demyelination, remyelination and axonal loss may be the outcome of variable dominant immunopathogenetic mechanisms in different multiple sclerosis patients.
Marburg O. (1906) Die sogenannte `akute Multiple Sklerose' . Jahrb Psychiatrie27: 211-312 .
2.
Lassmann H. (1997) Multiple sclerosis pathology. In: A. Compston (Ed) McAlpine's Multiple Sclerosis, 3rd Edition; Churchill Livingstone in press.
3.
Losseff NAet al. (1996) Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression . Brain119: 701-708 .
4.
Lassmann H. (1983) Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis . Schriftenr Neurol25: 1-35 .
5.
Prineas JWet al. (1993a) Multiple sclerosis: remyelination of nascent lesions . Ann Neurol33: 137-151 .
6.
Schlesinger H. (1909) Zur Frage der akuten multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter . Arb Neurol Inst (Wien)17: 410-432 .
7.
Dévic C. (1994) Myélite subaigue compliquée de névrite optique . Bull Med8: 1033-1033 .
Schilder P. (1912) Zur Kenntnis der sogenannten diffusen Sklerose (über Encephalitis periaxialis diffusa) . Z Gesamt Neurol Psychiatr10: 1-60 .
10.
Lucchinetti CF , Brück W , Rodriguez M , Lassmann H. (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis . Brain Pathol6: 259-274 .
11.
Haines JLet al. (1996) A genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The multiple sclerosis genetics group . Nature Genetics13: 469-471 .
12.
Sawcer Set al. (1996) A genomic screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 . Nature Genetics13: 464-468 .
13.
Ebers GCet al. (1996) A full genome search in multiple sclerosis . Nature Genetics13: 472-476 .
14.
Traugott U , Reinherz EL , Raine CS. (1983) Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages . J Neuroimmunol4: 201-221 .
15.
Esiri MM. (1977) Immunoglobulin-containing cells in multiple sclerosis plaques . Lancet2: 478-480 .
16.
Newcombe J , Li H , Cuzner ML. (1994) Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis . Neuropathol Apll Neurobiol20: 152-162 .
17.
Ulvestad Eet al. (1994) Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG . J Neurol Sci121: 125-131 .
18.
Brück Wet al. (1995) Monocyte/macrophage differentiation in early multiple sclerosis . Ann Neurol38: 788-796 .
19.
Washington Ret al. (1994) Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis . Ann Neurol35: 89-97 .
20.
Cannella B , Raine CS. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions . Ann Neurol37: 424-435 .
21.
Wucherpfenning KWet al.T-cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions . J Exp Med175: 993-1002 .
22.
Woodroofe MN , Cuzner ML. (1993) Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by nonradioactive in situ hybridization . Cytokine5: 583-588 .
23.
Ben-Nun A , Wekerle H , Cohen IR. (1981) The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis . Eur J Immunol11: 195-199 .
24.
Berger Tet al. (1997) Experimental autoimmune encephalomyelitis: The antigen specificity of T-lymphocytes determines the topography of lesions in the central and peripheral nervous system . Lab Invest76: 97-108 .
25.
Linington C , Bradl M , Lassmann H , Brunner C , Vass K. (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein . Am J Pathol130: 443-454 .
26.
Lassman H , Brunner C , Bradl M , Linington C. (1988) Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions . Acta Neuropathol75: 566-576 .
27.
Linington C , Engelhardt B , Kapocs G , Lassmann H. (1992) Induction of persistently demyelinating lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibodies . J Neuroimmunol40: 219-224 .
28.
Amor Set al. (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice . J Immunol153: 4349-4356 .
29.
Adelmann Met al. (1995) The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat . J Neuroimmunol63: 17-27 .
Bornstein MB , Appel SH. (1965) Tissue culture studies of demyelination . Ann NY Acad Sci122: 280-286 .
32.
Grundke Iqbal I , Bornstein MB. (1980) Multiple sclerosis: serum gamma globulin and demyelination in culture . Neurology30: 749-754 .
33.
Prineas JW , Graham JS (1981) Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown . Ann Neurol10: 149-158 .
34.
Gay D , Esiri M. (1991) Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytochemical study . Brain114: 557-572 .
35.
Hafler DA , Weiner HL. (1995) Immunologic mechanisms and therapy in multiple sclerosis . Immunol Rev144: 75-107 .
36.
Genain CPet al. (1996) Late complications of immune deviation therapy in a nonhuman primate . Science274: 2054-2057 .
37.
D'Souza S , Alinauskas K , McCrea E , Goodyer C , Antel JP. (1995) Differential susceptibility of human CNS-derived cell populations to TNF dependent and independent immune-mediated injury . JNeurosci15: 7293-7300 .
38.
Freedman MS , Ruijs TC , Selin LK , Antel JP. (1991) Peripheral blood gamma/delta T cells lyse fresh human brain derived oligodendrocytes . Ann Neurol30: 794-800 .
39.
Selmaj Ket al. (1991b) Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin . J Immunol147: 1522-1529 .
40.
Scolding N , Jones J , Compston DA , Morgan BP. (1990) Oligodendrocyte susceptibility to injury by T-cell perforin . Immunology70: 6-10 .
41.
D'Souza SDet al. (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death . J Exp Med184: 2361-2370 .
42.
Selmaj K , Brosnan CF , Raine CS. (1991a) Colocalization of lymphocytes bearing yd T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis . Proc Natl Acad Sci USA88: 6452-6456 .
43.
van Noort JMet al. (1995) A novel candidate autoantigen in multiple sclerosis: aB-crystallin, a small heat shock protein . Nature375: 798-801 .
44.
Dowling Pet al. (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain . J Exp Med184: 1513-1518 .
45.
Scolding NJet al. (1989). Normal rat serum cytotoxicity against syngeneic oligodendrocytes: Complement activation and attack in the absence of anti-myelin antibodies . J Neurol Sci89: 289-300 .
46.
Griot Cet al. (1990) Selective degeneration of oligodendrocytes mediated by reactive oxygen species . Free Radic Res Commun11: 181-193 .
47.
Selmaj KW , Raine CS. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro . Ann Neurol23: 339-346 .
48.
Probert Let al. (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor a . Proc Natl Acad Sci USA92: 11294-11298 .
49.
Hofman FM , Hinton DR , Johnson K , Merrill JE. (1989) Tumor necrosis factor identified in multiple sclerosis brain . J Exp Med170: 607-612 .
50.
Selmaj K , Raine CS , Cannella B , Brosnan CF. (1991c) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions . J Clin Invest87: 949-954 .
51.
Rosenthal A , Fujinami RS , Lampert PW. (1986) Mechanisms of Theiler's virus induced demyelination in nude mice . Lab Invest54: 515-522 .
52.
Jordan CAet al. (1989) Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a coronavirus . Glia2: 318-329 .
53.
Rodriguez M , Prayoonwiwat N , Howe C , Sanborn K. (1994) Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: a model for multiple sclerosis . J Neuropath Exp Neurol53: 136-143 .
54.
Barac-Lataset al. (1997) Patterns of oligodendroglia pathology in corona virus induced subacute demyelinating encephalomyelitis in the Lewis rat . Glia19: 1-12 .
55.
Readhead C , Schneider A , Griffiths I , Nave KA. (1994) Premature arrest of myelination in transgenic mice with increased proteolipid protein gene dosage . Neuron12: 583-595 .
56.
Kagawa Tet al. (1994) Glial cell degeneration and hypomyelination caused by overexpression of the myelin proteolipid gene . Neuron13: 427-442 .
57.
Montag Det al. (1994) Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin . Neuron13: 229-246 .
58.
Lassmann H , Bartsch U , Montag D , Schachner M. (1997) Dying back oligodendrogliopathy: A late sequal of myelin-associated glycoprotein deficiency . Glia19: 104-110 .
59.
Challoner PBet al. (1995) Plaque associated expression of human herpesvirus 6 in multiple sclerosis . Proc Natl Acad Sci USA92: 7440-7444 .
60.
Gendelman HEet al. (1985) A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases . Ann Neurol18: 324-328 .
61.
Rodriguez M , Scheithauer BW , Forbes G , Kelly PJ (1993) Oligodendrocyte injury is an early event in lesions of multiple sclerosis . Mayo Clin Proc68: 627-636 .
62.
Ozawa Ket al. (1994) Patterns of oligodendroglia pathology in multiple sclerosis . Brain117: 1311-1322 .
63.
Lassmann H , Suchanek G , Ozawa K. (1994) Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis . Ann Neurol36: S42-S46 .
64.
Brück Wet al. (1997) Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology . Ann Neurol in press.
65.
Heyes MP , Saito K , Markey SP. (1992) Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid . Biochem J283: 633-635 .
66.
Olney JW. (1983) Excitotoxins: an overview. In: K Fuxe , P Roberts and R Schwarcz (Eds). ExcitotoxinsMacmillan: London . 82-96.
67.
Chou SM , Wang HS , Taniguchi A. (1996) Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND . J Neurol Sci139: 16-26 .
68.
Raine CS , Scheinberg L , Waltz JM. (1981) Multiple sclerosis: Oligodendrocyte survival and proliferation in an active established lesion . Lab Invest45: 534-546 .
69.
Prineas JW , Kwon EE , Cho ES , Sharer LR. (1984) Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques . Ann NY Acad Sci436: 11-32 .
70.
Brück Wet al. (1994) Oligodendrocytes in the early course of multiple sclerosis . Ann Neurol35: 65-73 .
71.
Targett MPet al.1996) Failure to achieve remyelination of demyelinated rat axons following transplantation of gloal cells obtained from the adult human brain . Neuropathol Appl Neurobiol22: 199-206 .
Miller DJ , Asakura K , Rodriguez M. (1996). Central nervous system remyelination. Clinical application of basic neuroscience principles . Brain Pathol6: 331-344 .
74.
Storch MKet al. (1998) Multiple sclerosis: In situ evidence for antibody-and complement mediated demyelination . Ann Neurol43: 465-471 .
